Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kah Teong Soh
Observed name:
Kah Teong
Observed institutions:
Roswell Park Comprehensive Cancer Center,
Agenus (United States),
University at Buffalo, State University of New York
ORCID:
0000-0002-0146-0485
Observed ORCID:
0000-0002-0146-0485
OpenAlex ID:
A5032724293
Botensilimab, an Fc-Enhanced Anti–CTLA-4 Antibody, Is Effective against Tumors Poorly Responsive to Conventional Immunotherapy
2024
·
Dhan Chand
, David A. Savitsky
, et al.
·
Cancer Discovery
·
51
CD319 (SLAMF7) an alternative marker for detecting plasma cells in the presence of daratumumab or elotuzumab
2020
·
Kah Teong Soh
, Joseph D. Tario
, et al.
·
Cytometry Part B Clinical Cytometry
·
45
A phase 1/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndrome
2024
·
Terese C. Hammond
, Marco A. Purbhoo
, et al.
·
Nature Communications
·
42
PDF
Diagnosis of Plasma Cell Dyscrasias and Monitoring of Minimal Residual Disease by Multiparametric Flow Cytometry
2017
·
Kah Teong Soh
, Joseph D. Tario
, et al.
·
Clinics in Laboratory Medicine
·
36
Methodological considerations for the high sensitivity detection of multiple myeloma measurable residual disease
2019
·
Kah Teong Soh
, Joseph D. Tario
, et al.
·
Cytometry Part B Clinical Cytometry
·
33
PDF
Tumor and immune remodeling following radiotherapy in human renal cell carcinoma
2023
·
Jacky Chow
, Adil Khan
, et al.
·
Journal for ImmunoTherapy of Cancer
·
28
PDF
Evaluation of multiple myeloma measurable residual disease by high sensitivity flow cytometry: An international harmonized approach for data analysis
2022
·
Kah Teong Soh
, Neil Came
, et al.
·
Cytometry Part B Clinical Cytometry
·
27
PDF
Systemic infusion of TLR3-ligand and IFN-α in patients with breast cancer reprograms local tumor microenvironments for selective CTL influx
2023
·
Shipra Gandhi
, Mateusz Opyrchal
, et al.
·
Journal for ImmunoTherapy of Cancer
·
18
PDF
Evaluation of measurable residual disease in multiple myeloma by multiparametric flow cytometry: Current paradigm, guidelines, and future applications
2021
·
Kah Teong Soh
, Paul K. Wallace
·
International Journal of Laboratory Hematology
·
17
PDF
Monitoring of Measurable Residual Disease in Multiple Myeloma by Multiparametric Flow Cytometry
2019
·
Kah Teong Soh
, Paul K. Wallace
·
Current Protocols in Cytometry
·
17
RNA Flow Cytometry Using the Branched DNA Technique
2017
·
Kah Teong Soh
, Paul K. Wallace
·
Methods in molecular biology
·
17
Simultaneous, Single‐Cell Measurement of Messenger RNA, Cell Surface Proteins, and Intracellular Proteins
2016
·
Kah Teong Soh
, Joseph D. Tario
, et al.
·
Current Protocols in Cytometry
·
17
Development of a 27‐color panel for the detection of measurable residual disease in patients diagnosed with acute myeloid leukemia
2022
·
Kah Teong Soh
, Alexis Conway
, et al.
·
Cytometry Part A
·
14
470 Botensilimab, an Fc-enhanced CTLA-4 antibody, enhances innate and adaptive immune activation to promote superior anti-tumor immunity in cold and I-O refractory tumors
2022
·
Chloe Delepine
, Daniel Levey
, et al.
·
Regular and Young Investigator Award Abstracts
·
11
PDF
Lifetime physical inactivity is associated with increased risk for Hodgkin and non-Hodgkin lymphoma: A case-control study
2018
·
John Lewis Etter
, Rikki Cannioto
, et al.
·
Leukemia Research
·
9
Anti-PD-L2 immunotherapy is efficacious against melanoma in aged hosts through IL-17 and IFNγ signalling
2025
·
Carlos O. Ontiveros
, Myrna G. Garcia
, et al.
·
Nature Communications
·
5
PDF
The Allogeneic FAP-CAR-IL15 iNKT Therapy MiNK-215 Remodels the Tumor Stroma to Enhance Antitumor Immunity
2025
·
Eleni Chantzoura
, Efrat Altman-Sharoni
, et al.
·
Cancer Immunology Research
·
4
Abstract 1331: MiNK-215, an IL-15 armored FAP-targeting CAR iNKT cell therapy, effectively treats human organoid models of treatment-refractory MSS colorectal cancer (CRC) liver metastases
2024
·
Shanmugarajan Krishnan
, Bishnu Joshi
, et al.
·
Cancer Research
·
3
Monitoring Cell Proliferation by Dye Dilution: Considerations for Panel Design
2024
·
Joseph D. Tario
, Kah Teong Soh
, et al.
·
Methods in molecular biology
·
3
Abstract CT145: Systemic rintatolimod and interferon-α2b selectively reprogram local tumor microenvironment in patients with metastatic triple negative breast cancer for enhanced influx of cytotoxic T-lymphocytes but not regulatory T-cells
2022
·
Shipra Gandhi
, Mateusz Opyrchal
, et al.
·
Cancer Research
·
3
No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival
2016
·
Lara E. Sucheston-Campbell
, Rikki Cannioto
, et al.
·
Cancer Epidemiology Biomarkers & Prevention
·
3
Short-Term Storage of Mobilized Peripheral Blood Stem Cells in a Closed System Changes the Microenvironment and May Affect the Quantity of CD34+ and CD34+CD38-CD45RA-CD90+ Cells
2022
·
Amro Elshoury
, Orla Maguire
, et al.
·
Transplantation and Cellular Therapy
·
2
Supplementary Table S8 from Botensilimab, an Fc-Enhanced Anti–CTLA-4 Antibody, Is Effective against Tumors Poorly Responsive to Conventional Immunotherapy
2026
·
Dhan Chand
, David A. Savitsky
, et al.
Supplementary Figure S11 from Botensilimab, an Fc-Enhanced Anti–CTLA-4 Antibody, Is Effective against Tumors Poorly Responsive to Conventional Immunotherapy
2026
·
Dhan Chand
, David A. Savitsky
, et al.
Supplementary Table S7 from Botensilimab, an Fc-Enhanced Anti–CTLA-4 Antibody, Is Effective against Tumors Poorly Responsive to Conventional Immunotherapy
2026
·
Dhan Chand
, David A. Savitsky
, et al.
Show more works
View as search
Works count:
96
Citation count:
405
H-index:
13
I10-index:
14
Year
Topic
Type
